NCT06687993View on ClinicalTrials.gov

Acetylcholinesterase Inhibitor in Anorexia Nervosa: Multicenter, Double-Blind, Placebo-Controlled Trial

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

February 28, 2030

Study Completion Date

May 31, 2030

Conditions
Anorexia Nervosa Restricting Type
Interventions
DRUG

Donepezil 2.5 mg

2.5 mg daily oral intake for 90 days

DRUG

Donepezil 5 mg

5 mg daily oral intake for 90 days

DRUG

Placebo Comparator

daily oral intake for 90 days

All Listed Sponsors
collaborator

Université Paris Cité

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Centre Hospitalier St Anne

OTHER

NCT06687993 - Acetylcholinesterase Inhibitor in Anorexia Nervosa: Multicenter, Double-Blind, Placebo-Controlled Trial | Biotech Hunter | Biotech Hunter